| 000 | 01619 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513141300.0 | ||
| 264 | 0 | _c19980528 | |
| 008 | 199805s 0 0 eng d | ||
| 022 | _a0392-9590 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCooke, E D | |
| 245 | 0 | 0 |
_aTreatment of severe Raynaud's syndrome by injection of autologous blood pretreated by heating, ozonation and exposure to ultraviolet light (H-O-U) therapy. _h[electronic resource] |
| 260 |
_bInternational angiology : a journal of the International Union of Angiology _cDec 1997 |
||
| 300 |
_a250-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xblood |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aBacterial Proteins |
| 650 | 0 | 4 |
_aBlood _xdrug effects |
| 650 | 0 | 4 | _aBlood Flow Velocity |
| 650 | 0 | 4 |
_aBlood Transfusion, Autologous _xmethods |
| 650 | 0 | 4 | _aChaperonin 60 |
| 650 | 0 | 4 |
_aChaperonins _xblood |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aHot Temperature _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLaser-Doppler Flowmetry |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOzone _xtherapeutic use |
| 650 | 0 | 4 |
_aRaynaud Disease _xblood |
| 650 | 0 | 4 | _aSyndrome |
| 650 | 0 | 4 | _aUltraviolet Rays |
| 700 | 1 | _aPockley, A G | |
| 700 | 1 | _aTucker, A T | |
| 700 | 1 | _aKirby, J D | |
| 700 | 1 | _aBolton, A E | |
| 773 | 0 |
_tInternational angiology : a journal of the International Union of Angiology _gvol. 16 _gno. 4 _gp. 250-4 |
|
| 999 |
_c9510696 _d9510696 |
||